06 May 2009
Christopher Spillane
christopher.spillane@informausa.com
The US biotechnology industry was profitable for the first time last year but more companies are likely to sell themselves or go out of business, a new report has found. Ernst & Young's annual industry review found that the US sector had a full-year profit of $400 million.
The consultancy...
Please Login to read the full article.
RELATED CONTENT
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
